Search Results - "FENGJI XU"

NOEY2 (ARHI), an Imprinted Putative Tumor Suppressor Gene in Ovarian and Breast Carcinomas by Yu, Yinhua, Xu, Fengji, Peng, Hongqi, Fang, Xianjun, Zhao, Shulei, Li, Yang, Cuevas, Bruce, Kuo, Wen-Lin, Gray, Joe W., Siciliano, Michael, Mills, Gordon B., Bast, Robert C.

“…Using differential display PCR, we have identified a gene [NOEY2, ARHI (designation by the Human Gene Nomenclature Committee)] with high homology to ras and…”
Get full text

OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma: A critical appraisal by VAN HAAFTEN-DAY, Carolien, YU SHEN, FENGJI XU, YINHUA YU, BERCHUCK, Andrew, HAVRILESKY, Laura J, DE BRUIJN, H. W. A, VAN DER ZEE, Ate G. J, BAST, Robert C, HACKER, Neville F

“…Ovarian carcinoma remains the leading cause of death from gynecologic malignancy in Australia, the Netherlands, and the United States. CA-125-II, the most…”
Get full text

The Outcome of Heregulin-induced Activation of Ovarian Cancer Cells Depends on the Relative Levels of HER-2 and HER-3 Expression by FENGJI XU, YINHUA YU, LE, X.-F, BOYER, C, MILLS, G. B, BAST, R. C

“…Members of the epidermal growth factor receptor family of tyrosine kinases, including epidermal growth factor receptor, c-erbB-2 (HER-2), c-erbB-3 (HER-3), and…”
Get full text

Combination of Multiple Serum Markers Using an Artificial Neural Network to Improve Specificity in Discriminating Malignant from Benign Pelvic Masses by Zhang, Zhen, Barnhill, Stephen D., Zhang, Hong, Xu, Fengji, Yu, Yinhua, Jacobs, Ian, Woolas, Robert P., Berchuck, Andrew, Madyastha, K.R., Bast, Robert C.

“…A panel of four selected tumor markers, CA 125 II, CA 72-4, CA 15-3, and lipid-associated sialic acid, was analyzed collectively using an artificial neural…”
Get full text

Combinations of Multiple Serum Markers Are Superior to Individual Assays for Discriminating Malignant from Benign Pelvic Masses by Woolas, Robert P., Conaway, Mark R., Xu, Fengji, Jacobs, Ian J., Yu, Yinhua, Daly, Lee, Davies, Ann Prys, O'Briant, Kathy, Berchuck, Andrew, Soper, John T., Clarke-Pearson, Daniel L., Rodriguez, Gustavo, Oram, David H., Bast, Robert C.

“…To determine whether measurement of the levels of multiple tumor markers in the preoperative serum of women presenting with a pelvic mass distinguished benign…”
Get full text

ARHI suppresses pancreatic cancer by regulating MAPK/ERK 1/2 pathway by Hu, Yiqun, Yang, Hong, Lu, Xin-Qing, Xu, Fengji, Li, Jingnan, Qian, Jiaming

Get full text

OVX1 radioimmunoassay results are dependent on the method of sample collection and storage by HØGDALL, E. V. S, HØGDALL, C. K, KJAER, S. K, FENGJI XU, YINHUA YU, BAST, R. C, BLAAKAER, J, JACOBS, I. J

Get full text

Antibody-induced growth inhibition is mediated through immunochemically and functionally distinct epitopes on the extracellular domain of the c-erbB-2 (HER-2/neu) gene product p185 by Xu, F, Lupu, R, Rodriguez, G C, Whitaker, R S, Boente, M P, Berchuck, A, Yu, Y, DeSombre, K A, Boyer, C M, Bast, Jr, R C

“…Over-expression of the c-erbB-2 (HER-2/neu) gene product p185 occurs in 30% of breast and ovarian cancers. The p185 protein might serve as a target for…”
Get more information

Expression of a Murine Cytomegalovirus Early-Late Protein in “Latently” Infected Mice by Yu, Yinhua, Henry, Stanley C., Xu, Fengji, Hamilton, John D.

“…Monoclonal antibodies were isolated from the spleen of a latently infected mouse to identify possible antigenic markers for latent murine cytomegalovirus…”
Get full text

Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer by Zhang, Zhen, Yu, Yinhua, Xu, Fengji, Berchuck, Andrew, van Haaften-Day, Carolien, Havrilesky, Laura J, de Bruijn, Henk W.A, van der Zee, Ate G.J, Woolas, Robert P, Jacobs, Ian J, Skates, Steven, Chan, Daniel W, Bast, Robert C

“…Abstract Objective. Currently available tumor markers for ovarian cancer are still inadequate in both sensitivity and specificity to be used for…”
Get full text

The effect of antibodies and immunotoxins reactive with HER-2/neu on growth of ovarian and breast cancer cell lines by Rodríguez, G C, Boente, M P, Berchuck, A, Whitaker, R S, O'Briant, K C, Xu, F, Bast, Jr, R C

“…Because HER-2/neu is overexpressed in one third of breast and ovarian cancers, we examined the effect of unconjugated monoclonal antibodies (ID-5, PB-3, TA-1)…”
Get more information

Imprinted tumor suppressor gene ARHI induces apoptosis correlated with changes in DNA methylation in pancreatic cancer cells by Yang, Hong, Lu, Xingqing, Qian, Jiaming, Xu, Fengji, Hu, Yiqun, Yu, Yinhua, Bast, Robert C, Li, Jingnan

“…Aplesia Ras homologue member I (ARHI, DIRAS3) is a Ras-related imprinted growth inhibitory gene whose expression is down-regulated in the majority of breast…”
Get full text

ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancers by Peng, Hongqi, Xu, Fengji, Pershad, Rashmi, Hunt, Kelly K., Frazier, Marsha L., Berchuck, Andrew, Gray, Joe W., Hogg, David, Bast, Robert C., Yu, Yinhua

“…In our previous work, we had characterized ARHI as an imprinted putative tumor‐suppressor gene in ovarian and breast cancers. ARHI is expressed in primary…”
Get full text

Expression of p16 induces transcriptional downregulation of the RB gene by FANG, X, JIN, X, MILLS, G. B, XU, H.-J, LIU, L, PENG, H.-Q, HOGG, D, ROTH, J. A, YU, Y, XU, F, BAST, R. C

“…The RB and p16(INK4A) tumor suppressor genes function in the same pathway of cell cycle control. Previous evidence indicates that the p16(INK4A) gene is…”
Get full text

The human ARHI tumor suppressor gene inhibits lactation and growth in transgenic mice by Xu, F, Xia, W, Luo, R Z, Peng, H, Zhao, S, Dai, J, Long, Y, Zou, L, Le, W, Liu, J, Parlow, A F, Hung, M C, Bast, Jr, R C, Yu, Y

“…ARHI is a novel imprinted tumor suppressor gene. To study its function in vivo, we have developed transgenic mice that overexpress ARHI. Offspring bearing the…”
Get full text

OVX1, macrophage‐colony stimulating factor, and CA‐125‐II as tumor markers for epithelial ovarian carcinoma by van Haaften‐Day, Carolien, Shen, Yu, Xu, Fengji, Yu, Yinhua, Berchuck, Andrew, Havrilesky, Laura J., de Bruijn, H. W. A., van der Zee, Ate G. J., Bast, Robert C., Hacker, Neville F.

“…BACKGROUND Ovarian carcinoma remains the leading cause of death from gynecologic malignancy in Australia, the Netherlands, and the United States. CA‐125‐II,…”
Get full text

The human ARHI tumor suppressor gene inhibits lactation and growth in transgenic micel by FENGJI XU, WEIYA XIA, PARLOW, Albert F, HUNG, Mien-Chie, BAST, Robert C, YINHUA YU, LUO, Robert Z, HONGQI PENG, SHULEI ZHAO, JIANYU DAI, YAN LONG, LINGLONG ZOU, WEIDONG LE, JINSONG LIU

Get full text

Genomic structure and promoter characterization of an imprinted tumor suppressor gene ARHI by Luo, Robert Z., Peng, Hongqi, Xu, Fengji, Bao, Jiaju, Pang, Yong, Pershad, Rashmi, Issa, Jean-Pierre J., Liao, Warren S.-L., Bast, Robert C., Yu, Yinhua

“…We have recently identified a maternally imprinted tumor suppressor gene, ARHI (aplysia ras homolog I), the expression of which is lost in ovarian and breast…”
Get full text

Synergistic Interaction between Anti-p185HER-2 Ricin A Chain Immunotoxins and Radionuclide Conjugates for Inhibiting Growth of Ovarian and Breast Cancer Cells That Overexpress HER-2 by FENGJI XU, LEADON, S. A, ZALUTSKY, M. R, BAST, R. C, YINHUA YU, BOYER, C. M, O'BRIANT, K, WARD, K, MCWATTERS, A, XIAOGUANG ZHAO, DUK SOO BAE, DESOMBRE, K

“…Radionuclide conjugates or ricin A chain (RTA) immunotoxins that target pl85 HER-2 have partially inhibited the growth of human ovarian cancer xenografts in…”
Get full text